SEC Form 4 · accession 0001209191-15-056004
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Bradbury
Director
Period of report
Jun 23, 2015
Accepted (ET)
Jun 24, 2015 · 6:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Jun 23, 2015 | S | 10,000 | $6.92 | D | 307,925 | I | BioBrit, LLC. |
| Common stockF2 | Jun 24, 2015 | S | 10,000 | $6.57 | D | 297,925 | I | BioBrit, LLC. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average sale price for the entire number of shares sold. The sale prcies range from $6.77 to $7.27 per share.
- F2Represents the weighted average sale price for the entire number of shares sold. The sale prcies range from $6.47 to $6.68 per share.